These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8237297)

  • 21. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease.
    Sternic N; Kacar A; Filipovic S; Svetel M; Kostic VS
    Clin Neuropharmacol; 1998; 21(2):93-6. PubMed ID: 9579294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cheese effect and new reversible MAO-A inhibitors. Proceedings of the round table of the International Conference on New Directions in Affective Disorders, Jerusalem, April 5-9, 1987.
    J Neural Transm Suppl; 1988; 26():1-136. PubMed ID: 3162947
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug interactions with reversible monoamine oxidase-A inhibitors.
    Callingham BA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S42-50. PubMed ID: 8313396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
    Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M
    Adv Neurol; 1996; 69():595-8. PubMed ID: 8615185
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical overview on moclobemide.
    Tiller JW
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):703-12. PubMed ID: 8255982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemistry and pharmacology of moclobemide, a prototype RIMA.
    Haefely W; Burkard WP; Cesura AM; Kettler R; Lorez HP; Martin JR; Richards JG; Scherschlicht R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S6-14. PubMed ID: 1546143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selective inhibition of monoamine oxidase in bovine brain by befol and moclobemide].
    Moskvitina TA; Gankina EM; Val'dman AV
    Vopr Med Khim; 1991; 37(2):49-51. PubMed ID: 1897195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study.
    van Haelst IM; van Klei WA; Doodeman HJ; Kalkman CJ; Egberts TC;
    J Clin Psychiatry; 2012 Aug; 73(8):1103-9. PubMed ID: 22938842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
    Dingemanse J; Hussain Y; Korn A
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacology of reversible MAO-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():345A-346A. PubMed ID: 1498864
    [No Abstract]   [Full Text] [Related]  

  • 32. Depression: advances in drug treatment.
    Hopkins S
    Nurs Stand; 1993 Nov 24-30; 8(10):36. PubMed ID: 8297750
    [No Abstract]   [Full Text] [Related]  

  • 33. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI; Herrmann N; Walker SE
    CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moclobemide in patients with dementia and depression.
    Amrein R; Martin JR; Cameron AM
    Adv Neurol; 1999; 80():509-19. PubMed ID: 10410765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibitory monoamine oxidases of the new generation].
    Nowakowska E; Chodera A
    Pol Merkur Lekarski; 1997 Jul; 3(13):1-4. PubMed ID: 9432289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidural anaesthesia, ephedrine and phenylephrine in a patient taking moclobemide, a new monoamine oxidase inhibitor.
    Martyr JW; Orlikowski CE
    Anaesthesia; 1996 Dec; 51(12):1150-2. PubMed ID: 9038453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies.
    Amrein R; Güntert TW; Dingemanse J; Lorscheid T; Stabl M; Schmid-Burgk W
    Psychopharmacology (Berl); 1992; 106 Suppl():S24-31. PubMed ID: 1546135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiolytic and memory improving effects of moclobemide.
    Nowakowska E; Chodera A; Kus K; Rybakowski J
    Arzneimittelforschung; 1998 Jun; 48(6):625-8. PubMed ID: 9689417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoamine oxidase inhibitors. An update on drug interactions.
    Livingston MG; Livingston HM
    Drug Saf; 1996 Apr; 14(4):219-27. PubMed ID: 8713690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moclobemide effects on prolactin plasma levels in healthy individuals: the hormonal increase induced by a single dose is maintained during a 4-week period of drug intake.
    Juruena MF; Pires ML; Calil HM
    Int Clin Psychopharmacol; 1997 Nov; 12(6):317-21. PubMed ID: 9547133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.